Skip to results
Modify your search
NARROW
1-20 of 108
Section: Original Articles
Sort by
Journal Article
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients
Danilo Menichelli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f11–f19, https://doi.org/10.1093/ehjcvp/pvab002
Published: 25 January 2021
Journal Article
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Giuseppe Gargiulo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f50–f60, https://doi.org/10.1093/ehjcvp/pvaa116
Published: 29 October 2020
Journal Article
Depressive symptoms and non-adherence to treatable cardiovascular risk factors’ medications in the CONSTANCES cohort
Nadine Hamieh and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 280–286, https://doi.org/10.1093/ehjcvp/pvaa124
Published: 28 October 2020
Journal Article
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials
Anna Plitt and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f40–f49, https://doi.org/10.1093/ehjcvp/pvaa120
Published: 16 October 2020
Journal Article
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study
Joris R de Groot and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f30–f39, https://doi.org/10.1093/ehjcvp/pvaa079
Published: 13 August 2020
Journal Article
Patient-reported outcomes and medication adherence in patients with heart failure
Anne Ankerstjerne Rasmussen and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 287–295, https://doi.org/10.1093/ehjcvp/pvaa097
Published: 06 August 2020
Journal Article
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome
Alberto Giannoni and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 180–188, https://doi.org/10.1093/ehjcvp/pvaa089
Published: 15 July 2020
Journal Article
Adherence to prescribed medications in patients with heart failure: insights from liquid chromatography–tandem mass spectrometry-based urine analysis
Joanne Simpson and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 296–301, https://doi.org/10.1093/ehjcvp/pvaa071
Published: 29 June 2020
Journal Article
Risk of infections in patients treated with ticagrelor vs. clopidogrel: a systematic review and meta-analysis
Hang Long Li and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 171–179, https://doi.org/10.1093/ehjcvp/pvaa065
Published: 22 June 2020
Journal Article
P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients
Matteo Bianco and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 196–205, https://doi.org/10.1093/ehjcvp/pvaa038
Published: 16 June 2020
Journal Article
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
Christina J -Y Lee and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f3–f10, https://doi.org/10.1093/ehjcvp/pvaa063
Published: 12 June 2020
Journal Article
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database
Joachim Alexandre and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 312–320, https://doi.org/10.1093/ehjcvp/pvaa037
Published: 30 April 2020
Journal Article
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial
Apostolos Tzikas and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f63–f71, https://doi.org/10.1093/ehjcvp/pvaa039
Published: 27 April 2020
Journal Article
Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Joris J Komen and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f72–f80, https://doi.org/10.1093/ehjcvp/pvaa017
Published: 23 April 2020
Journal Article
Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies
Felix Hofer and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 189–195, https://doi.org/10.1093/ehjcvp/pvaa027
Published: 14 April 2020
Journal Article
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
Paul Guedeney and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 225–235, https://doi.org/10.1093/ehjcvp/pvaa024
Published: 10 April 2020
Journal Article
Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study
Marco Proietti and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f84–f92, https://doi.org/10.1093/ehjcvp/pvaa015
Published: 04 March 2020
Journal Article
Aspirin-omitted dual antithrombotic therapy in non-valvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis
Cheng-Feng Luo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 218–224, https://doi.org/10.1093/ehjcvp/pvaa016
Published: 04 March 2020
Journal Article
Smoking and antiplatelet therapy after acute coronary syndromes
Marcus Flather and Sarah Ayton
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 382–383, https://doi.org/10.1093/ehjcvp/pvaa007
Published: 25 February 2020
Journal Article
All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart disease
Jarl Emanuel Strange and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue FI1, April 2021, Pages f93–f100, https://doi.org/10.1093/ehjcvp/pvaa011
Published: 17 February 2020
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals